SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.

Harris, Julie R; Owusu, Daniel; O'Laughlin, Kevin; Cohen, Adam L; Ben Hamida, Amen; Patel, Jaymin C; Freeman, Molly M; Nsibambi, Thomas; Nieves, Rebecca; Marston, Barbara J; Wasike, Samuel; Galbraith, Jennifer S; Boore, Amy L; Nelson, Lisa J; Guagliardo, Sarah Anne J; Klena, John D; Patel, Ketan; Ma, Marek

Harris, Julie R; Owusu, Daniel; O'Laughlin, Kevin; Cohen, Adam L; Ben Hamida, Amen; Patel, Jaymin C; Freeman, Molly M; Nsibambi, Thomas; Nieves, Rebecca; Marston, Barbara J; Wasike, Samuel; Galbraith, Jennifer S; Boore, Amy L; Nelson, Lisa J; Guagliardo, Sarah Anne J; Klena, John D; Patel, Ketan; Ma, Marek.

Emerg Infect Dis ; 28(6): 1279-1280, 2022 06.

Article em En | MEDLINE | ID: mdl-35470796

ABSTRACT

ABSTRACT

The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally.

Assuntos

COVID-19; SARS-CoV-2; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; SARS-CoV-2/genética; Uganda/epidemiologia

Palavras-chave

COVID-19; SARS; SARS-CoV-2; US Embassy; Uganda; breakthrough; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Emerg Infect Dis Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google